Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Alexandroupoli – page 9

111 clinical trials in Alexandroupoli, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Alexandroupoli at a glance
111
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

111 trials in Alexandroupoli

Open in trial search

Anaemia+1

Not recruiting

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:AG-946
  • Sponsor:Agios Pharmaceuticals Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Celgene Corp.

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC

Sepsis

Not recruiting

Study on Avibactam and Drug Combination for Treating Severe Infections in Patients

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Anidulafungin
  • Sponsor:Hellenic Institute For The Study Of Sepsis

Study of Zilovertamab Vedotin with Drug Combination for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Merck Sharp & Dohme LLC

COVID-19

Not recruiting

Study on the Effects of S-217622 for Adults Hospitalized with COVID-19

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:(6E)-6-[(6-Chloro-2-Methyl-2H-Indazol-5-Yl)Imino]-3-[(1-Methyl-1H-1,2,4-Triazol-3-Yl)Methyl]-1-[(2,4,5-Trifluorophenyl)Methyl]-1,3,5-Triazinane-2,4-Dione
  • Sponsor:University Of Minnesota

Acute kidney injury

Not recruiting

Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Ravulizumab
  • Sponsor:Alexion Pharmaceuticals Inc.

Colitis ulcerative

Not recruiting

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Epoetin Alfa
  • Sponsor:Celgene Corp.

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Marginal zone lymphoma+1

Not recruiting

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:BeOne Medicines AG

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Alexandroupoli

What the registry says about research in the country

01 Hematologic Oncology

Innovative clinical trials focusing on multiple myeloma and various types of lymphoma, testing new combination therapies and treatment approaches for both newly diagnosed and relapsed/refractory patients.

  • Multiple Myeloma Studies
  • Large B-Cell Lymphoma Research
  • Plasma Cell Disorders

Research includes evaluation of novel drug combinations and maintenance therapies post-transplantation.

02 Cardiovascular & Renal Studies

Comprehensive research investigating treatments for chronic kidney disease and cardiovascular conditions, with a focus on combination therapies and novel compounds.

  • Hypertension Management
  • Heart Failure Treatments
  • Kidney Disease Interventions

Studies aim to improve outcomes in patients with combined cardiovascular and renal conditions.

03 Respiratory Medicine

Advanced clinical research in pulmonary conditions, including studies on asthma treatments and innovative therapies for various respiratory infections.

  • Asthma Management
  • Pulmonary Fibrosis
  • Respiratory Infections

Investigations include both established and novel therapeutic approaches for respiratory diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.